Multimodal gold nanoparticles as potential radiopharmaceuticals in targeted radionuclide therapy
2018/31/D/ST4/01488
Keywords
Descriptors
- ST4_16: Chemia jądrowa i radiacyjna
- ST4_2: Nanochemia
- ST4_18: Inne zagadnienia pokrewne
Panel
ST4 – Chemistry: physical chemistry/chemical physics, theoretical chemistry, analytical chemistry, inorganic chemistry, organic chemistry, method development
Host institution
Instytut Chemii i Techniki Jądrowej
Voivodeship: mazowieckie
Principal investigator (from the host institution)
Number of co-investigators in the project: 4
Call
SONATA 14 – announced on 2018-09-14
- Amount awarded
- 776 400 PLN
- Project start date
- 2019-07-01
- Project end date
- 2023-06-30
- Project duration
- 48 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- komputer z oprogramowaniem. Cost: 10 000 PLN
- mikroskop fluorescencyjny wraz z kamerą. Cost: 100 000 PLN
Information in the final report
Publication in academic press/journals (4)
-
Lipidic Cubic-Phase Nanoparticles (Cubosomes) Loaded with Doxorubicin and Labeled with 177Lu as a Potential Tool for Combined Chemo and Internal Radiotherapy for Cancers
- Authors:
- Adrianna Cytryniak, Ewa Nazaruk, Renata Bilewicz, Emilia Górzyńska, Kinga Żelechowska-Matysiak, Rafał Walczak, Adam Mames, Aleksander Bilewicz, Agnieszka Majkowska-Pilip*
- Academic press:
- Nanomaterials (year: 2020, volume: 10, pages: 2286), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/nano10112272 – link to the publication
-
Nanoparticles in Targeted Alpha Therapy
- Authors:
- Agnieszka Majkowska-Pilip*, Weronika Gawęda, Kinga Żelechowska-Matysiak, Kamil Wawrowicz, Aleksander Bilewicz
- Academic press:
- Nanomaterials (year: 2020, volume: 10, pages: 1366-1391), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/nano10071366 – link to the publication
-
Improvement of the effectiveness of HER2+ cancer therapy by use of doxorubicin and trastuzumab modified radioactive gold nanoparticles
- Authors:
- Kinga Żelechowska-Matysiak, Evangelia-Alexandra Salvanou, Penelope Bouziotis, Tadeusz Budlewski, Aleksander Bilewicz, Agnieszka Majkowska-Pilip
- Academic press:
- Molecular Pharmceutics (year: 2023, volume: 20, pages: 4676-4686), Publisher: ACS
- Status:
- Published
- DOI:
- 10.1021/acs.molpharmaceut.3c00414 – link to the publication
-
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers
- Authors:
- K. Żelechowska-Matysiak, K. Wawrowicz, M. Wierzbicki, T. Budlewski, A. Bilewicz, A. Majkowska-Pilip
- Academic press:
- Molecules (year: 2023, volume: 28(6), pages: 2451), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/molecules28062451 – link to the publication